Bajaj Finserv Healthcare Fund · Regular · Growth
NAV
₹12.0680
as of 16 Nov 2026
Expense Ratio
2.59%
AUM
₹389 Cr
Lumpsum returns (CAGR)
- 1Y
- +21.10%
- 3Y
- —
- 5Y
- —
- Since Inception
- +10.48%
SIP returns (XIRR)
- 1Y
- +33.78%
- 3Y
- —
- 5Y
- —
- Since Inception
- +21.40%
Not enough verified history to show honest backtest scenarios (this fund is under 3 years old).
Risk Metrics
Trailing 1 year, annualised0.92
Sharpe Ratio
+0.14
Alpha
0.62
Beta
0.92
Sortino
12.67%
Std Dev
-11.14%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 Oct 2026- Pharmaceuticals & Biotechnology73.91%
- Healthcare Services15.89%
- Food Products1.92%
- Consumer Durables1.88%
- Chemicals & Petrochemicals1.16%
- Insurance0.47%
- Fertilizers & Agrochemicals0.15%
Each sector links to the mutual funds most exposed to it.
Related reading
Thinking about Bajaj Finserv Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Divi'S Laboratories Limited8.76%
- 2Sun Pharmaceutical Industries Limited8.48%
- 3Piramal Pharma Limited7.11%
- 4Apollo Hospitals Enterprise Limited6.44%
- 5Aurobindo Pharma Limited5.87%
- 6Rubicon Research Limited5.84%
- 7Laurus Labs Limited4.59%
- 8Torrent Pharmaceuticals Limited4.44%
- 9Dr. Reddy'S Laboratories Limited3.96%
- 10Emcure Pharmaceuticals Limited3.76%
What this fund does
Bajaj Finserv Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Bajaj Finserv Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by Bajaj Finserv Mutual Fund. The fund has been operational for over 1 years. It manages assets worth ₹389 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE HEALTHCARE TOTAL RETURN INDEX (TRI). The current expense ratio is 2.59%.